InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Purdy Graham, Directrice. Officer active across 1 companies, notably Turning Point Brands, Inc.. Cumulatively, 7 disclosures have been recorded. Total volume traded: €65k. The latest transaction was disclosed on 14 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
02,500 shares0
Common Stock
SEC:0001567619-22-007046:0·
€269,2608,970 shares@ €30.01780.013% mcap80.5% of flow
Common Stock
SEC:0001567619-22-002682·
€269,2608,970 shares@ €30.01780.013% mcap40.2% of flow
Common Stock
SEC:0001567619-22-002682:0·
€32,6781,000 shares@ €32.67830.0016% mcap9.8% of flow
Common Stock
SEC:0001567619-21-018973·
Ideal exit: 25 Jul 2022 (T+270)
€32,6781,000 shares@ €32.67830.0016% mcap4.9% of flow
Common Stock
SEC:0001567619-21-018973:0·
Ideal exit: 25 Jul 2022 (T+270)
€32,6781,000 shares@ €32.67830.0016% mcap9.8% of flow
Common Stock
SEC:0001567619-21-018867·
€32,6781,000 shares@ €32.67830.0016% mcap4.9% of flow
Common Stock
SEC:0001567619-21-018867:0·
7 of 7 declarations
About Purdy Graham
Jennifer M. Carter is a Director at Augmedix, Inc. She contributes to the strategy and governance of the company, bringing her expertise in the technology sector. Her role is essential in guiding strategic decisions and ensuring the smooth operation of the organization.
